Flanders Institute for Biotechnology / Vlaams Instituut voor Biotechnologie (VIB)

Research / Science organisation

Flanders, Belgium

Publications in cooperation with FAU scientists

Go to first page Go to previous page 2 of 3 Go to next page Go to last page
Painter, J.N., O'Mara, T.A., Marquart, L., Webb, P.M., Attia, J., Medland, S.E.,... Spurdle, A.B. (2016). Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer. Cancer Epidemiology Biomarkers & Prevention, 25(11), 1503-1510. https://dx.doi.org/10.1158/1055-9965.EPI-16-0147
French, J.D., Johnatty, S.E., Lu, Y., Beesley, J., Gao, B., Kalimutho, M.,... Macgregor, S. (2016). Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget, 7(6), 6353-68. https://dx.doi.org/10.18632/oncotarget.7047
Permuth, J.B., Reid, B., Earp, M., Chen, Y.A., Monteiro, A.N.A., Chen, Z.,... Sellers, T.A. (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget, 7(45), 72381-72394. https://dx.doi.org/10.18632/oncotarget.10546
Easton, D.F., Lesueur, F., Decker, B., Michailidou, K., Li, J., Allen, J.,... Chenevix-Trench, G. (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics, 53(5), 298-309. https://dx.doi.org/10.1136/jmedgenet-2015-103529
Pelttari, L.M., Khan, S., Vuorela, M., Kiiski, J.I., Vilske, S., Nevanlinna, V.,... Nevanlinna, H. (2016). RAD51B in Familial Breast Cancer. PLoS ONE, 11(5). https://dx.doi.org/10.1371/journal.pone.0153788
Liu, J., Loncar, I., Collee, J.M., Bolla, M.K., Dennis, J., Michailidou, K.,... Hollestelle, A. (2016). rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific Reports, 6. https://dx.doi.org/10.1038/srep36874
Carvajal-Carmona, L.G., O'Mara, T.A., Painter, J.N., Lose, F.A., Dennis, J., Michailidou, K.,... Thompson, D.J. (2015). Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Human genetics, 134(2), 231-45. https://dx.doi.org/10.1007/s00439-014-1515-4
Lawrenson, K., Li, Q., Kar, S., Seo, J.-H., Tyrer, J., Spindler, T.J.,... Defazio, A. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications, 6, 8234. https://dx.doi.org/10.1038/ncomms9234
Chornokur, G., Lin, H.-Y., Tyrer, J.P., Lawrenson, K., Dennis, J., Amankwah, E.K.,... Phelan, C.M. (2015). Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS ONE, 10(6), e0128106. https://dx.doi.org/10.1371/journal.pone.0128106
Pirie, A., Guo, Q., Kraft, P., Canisius, S., Eccles, D.M., Rahman, N.,... Schmidt, M.K. (2015). Common germline polymorphisms associated with breast cancer-specific survival. Breast Cancer Research, 17, 58. https://dx.doi.org/10.1186/s13058-015-0570-7
Lawrenson, K., Iversen, E.S., Tyrer, J., Weber, R.P., Concannon, P., Hazelett, D.J.,... Schildkraut, J.M. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis, 36(11), 1341-53. https://dx.doi.org/10.1093/carcin/bgv138
Lee, A.W., Tyrer, J.P., Doherty, J.A., Stram, D.A., Kupryjanczyk, J., Dansonka-Mieszkowska, A.,... Pearce, C.L. (2015). Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology, 136(3), 542-8. https://dx.doi.org/10.1016/j.ygyno.2014.12.017
Painter, J.N., O'Mara, T.A., Batra, J., Cheng, T., Lose, F.A., Dennis, J.,... Spurdle, A.B. (2015). Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Human Molecular Genetics, 24(5), 1478-92. https://dx.doi.org/10.1093/hmg/ddu552
Hein, A., Lambrechts, D., Von Minckwitz, G., Haeberle, L., Eidtmann, H., Tesch, H.,... Fasching, P. (2015). Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study. International Journal of Cancer, 137(12), 2981-8. https://dx.doi.org/10.1002/ijc.29656
Johnatty, S.E., Tyrer, J.P., Kar, S., Beesley, J., Lu, Y., Gao, B.,... Chenevix-Trench, G. (2015). Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research, 21(23), 5264-76. https://dx.doi.org/10.1158/1078-0432.CCR-15-0632
Zhang, B., Shu, X.-O., Delahanty, R.J., Zeng, C., Michailidou, K., Bolla, M.K.,... Zheng, W. (2015). Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. Journal of the National Cancer Institute, 107(11). https://dx.doi.org/10.1093/jnci/djv219
Kabisch, M., Bermejo, J.L., Duennebier, T., Ying, S., Michailidou, K., Bolla, M.K.,... Hamann, U. (2015). Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. Carcinogenesis, 36(2), 256-71. https://dx.doi.org/10.1093/carcin/bgu326
Rudolph, A., Milne, R.L., Truong, T., Knight, J.A., Seibold, P., Flesch-Janys, D.,... Chang-Claude, J. (2015). Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. International Journal of Cancer, 136(6), E685-96. https://dx.doi.org/10.1002/ijc.29188
Garg, A.D., Galluzzi, L., Apetoh, L., Baert, T., Birge, R.B., Bravo-San Pedro, J.M.,... Agostinis, P. (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology, 6, 588. https://dx.doi.org/10.3389/fimmu.2015.00588
Kar, S.P., Tyrer, J.P., Li, Q., Lawrenson, K., Aben, K.K.H., Anton-Culver, H.,... Pharoah, P.D.P. (2015). Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk. Cancer Epidemiology Biomarkers & Prevention, 24(10), 1574-84. https://dx.doi.org/10.1158/1055-9965.EPI-14-1270

Last updated on 2016-10-05 at 08:26